Arizona has become the latest state to seek permission from the federal government to limit the number of medicines that would be covered by its state Medicaid program, which is currently required to provide coverage for all treatments.
In a Nov. 17 letter to the U.S. Centers for Medicare and Medicaid Services, state officials argued they should be allowed to use the same tools that commercial insurers rely on to contain drug costs. And they insist such a move is needed in order to preserve the larger mission of providing adequate health coverage. Massachusetts made the same request in late September.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
